Market Value3,152,681,097
Total Holdings71
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ITCI / Intra-Cellular Therapies, Inc.
FATE / Fate Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
NKTR / Nektar Therapeutics
AGEN / Agenus Inc.
EWTX / Edgewise Therapeutics, Inc.
ZURA / Zura Bio Limited
ALKS / Alkermes plc
APGE / Apogee Therapeutics, Inc.
ALEC / Alector, Inc.
ORKA / Oruka Therapeutics, Inc.
AVTX / Avalo Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
CYBN / Cybin Inc.
ALGS / Aligos Therapeutics, Inc.
MNMD / Mind Medicine (MindMed) Inc.
AKRO / Akero Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
ALLK / Allakos Inc.
SYRE / Spyre Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
SRRK / Scholar Rock Holding Corporation
MGX / Metagenomi, Inc.
TVTX / Travere Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
TGTX / TG Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
DVAX / Dynavax Technologies Corporation
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
OCUL / Ocular Therapeutix, Inc.
ANIP / ANI Pharmaceuticals, Inc.
KRRO / Korro Bio, Inc.
APLS / Apellis Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
INSM / Insmed Incorporated
ENGN / enGene Holdings Inc.
INO / Inovio Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
MBX / MBX Biosciences, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
GH / Guardant Health, Inc.
PRAX / Praxis Precision Medicines, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
AMGN / Amgen Inc.
COGT / Cogent Biosciences, Inc.
ALGS / Aligos Therapeutics, Inc.
HLVX / HilleVax, Inc.
CYBN / Cybin Inc.
NMRA / Neumora Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc. Call
VIGL / Vigil Neuroscience, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
FDMT / 4D Molecular Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
RNA / Avidity Biosciences, Inc.
KYMR / Kymera Therapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
NTLA / Intellia Therapeutics, Inc.
IVVD / Invivyd, Inc.
RGLS / Regulus Therapeutics Inc.
ETNB / 89bio, Inc.
PLRX / Pliant Therapeutics, Inc.
PRTA / Prothena Corporation plc
AXSM / Axsome Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc. Call
ANRO / Alto Neuroscience, Inc.
CNTX / Context Therapeutics Inc.
EDIT / Editas Medicine, Inc.
SWTX / SpringWorks Therapeutics, Inc.
GERN / Geron Corporation
CLYM / Climb Bio, Inc.
KURA / Kura Oncology, Inc.
TERN / Terns Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.